No link found for metformin or statins and ovarian cancer

No link found for metformin or statins and ovarian cancer

(HealthDay)—In women with type 2 diabetes, no evidence was found of an association between the use of metformin or statins and the incidence of ovarian cancer, according to a study published online Feb. 7 in BJOG: An International Journal of Obstetrics and Gynaecology.

Elina Urpilainen, from the University of Oulu in Finland, and colleagues used national registers to identify 137,643 women (>40 years old) diagnosed with type 2 diabetes in Finland from 1996 through 2011.

The researchers found that 303 women were diagnosed with ovarian cancer during the follow-up period. Metformin was not associated with the incidence of ovarian cancer (hazard ratio, 1.02) compared to other oral antidiabetic medications. There was also no association noted between ovarian cancer incidence and statins (hazard ratio, 0.99).

"No evidence of an association between the use of or statins and the incidence of in patients with type 2 diabetes was found," the authors write.


Explore further

USPSTF recommends against ovarian cancer screening

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: No link found for metformin or statins and ovarian cancer (2018, February 27) retrieved 14 October 2019 from https://medicalxpress.com/news/2018-02-link-metformin-statins-ovarian-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more